Meath councillor calls for reinstatement of glucose monitoring funding for cystic fibrosis patients
A Meath councillor has called on the Government and the HSE to reinstate funding for continuous glucose monitoring (CGM) systems for people living with cystic fibrosis-related diabetes, warning that the withdrawal of supports is putting patients’ health at risk.
At this month’s meeting of Meath County Council, Fine Gael Councillor Sarah Reilly proposed that the local authority write to the Minister for Health and the HSE to restore funding through the Primary Care Reimbursement Service (PCRS).
Until recently, CGMs were provided to all patients with CF-related diabetes on insulin, but funding for new patients was discontinued in January 2024.
Cllr Reilly told councillors that the devices — which allow for real-time tracking of blood glucose levels — were “a vital tool” in managing the condition.
“Continuous glucose sensors help prevent dangerous highs and lows and enable better long-term health outcomes,” she said.
“For people with cystic fibrosis, maintaining stable glucose levels is essential, as elevated blood sugars can significantly impact lung function, weight maintenance, and overall disease progression.”
She said the “sudden” withdrawal of funding had placed a “significant burden” on patients and families, both financially and medically.
“Many are now struggling to manage their condition effectively without proper tools,” Cllr Reilly said.
“CGMs are not a luxury — they are a proven, cost-effective means of reducing hospital admissions, improving quality of life, and enabling patients to manage their health with greater independence.”
The motion was supported by councillors, who agreed to write to the Minister for Health and the HSE seeking the reinstatement of the funding.